Assay Development
$1,987,944U54FY2010HGNIH
Broad Institute, Inc., Cambridge MA
Investigators
Linked publications & trials
Paper 29227471Paper 28340340Paper 28182563Paper 27994748Paper 27694802Paper 27641501Paper 27573496Paper 27128528Paper 26901445Paper 26873923Paper 26839313Paper 26705509Paper 26656089Paper 26046436Paper 25958245Paper 25900219Paper 25556942Paper 25477388Paper 25454272Paper 25336726Paper 25211597Paper 25024206Paper 24824984Paper 24710340Paper 24518064Paper 24312513Paper 24045582Paper 23585218Paper 23562243Paper 23487248Paper 23403082Paper 22941295Paper 22863010Paper 22503247Paper 22497765Paper 22297109Paper 22172704Paper 22117901Paper 22018462Paper 21956170Paper 21927648Paper 21802942Paper 21685049Paper 21455318Paper 20550176Paper 20547534Paper 20041172
Abstract
B. Assay Development and Adaptation Core The assay development and adaptation core will be responsible for the development and evaluation of physiologically relevant and disease-related assays, adaptation of these assays for automated HTS and HCS, and guidance to collaborators for further assay development. This includes the development and implementation of physiologically relevant counter screens and secondary assays.
View original record on NIH RePORTER →